<!DOCTYPE html>
<html>
<head>
<meta http-equiv="X-UA-Compatible" content="IE=Edge" />
<meta charset="utf-8" />
</head>

<body style="margin: 0;">

<div id="p177" style="overflow: hidden; position: relative; background-color: white; width: 1210px; height: 935px;">
<style class="shared-css" type="text/css" >
.t {
	transform-origin: bottom left;
	z-index: 2;
	position: absolute;
	white-space: pre;
	overflow: visible;
	line-height: 1.5;
}
.text-container {
	white-space: pre;
}
@supports (-webkit-touch-callout: none) {
	.text-container {
		white-space: normal;
	}
}
</style>
<style type="text/css" >

#t1_177{left:35px;bottom:24px;letter-spacing:-0.34px;word-spacing:0.13px;}
#t2_177{left:306px;bottom:30px;}
#t3_177{left:313px;bottom:24px;letter-spacing:0.16px;}
#t4_177{left:346px;bottom:30px;}
#t5_177{left:351px;bottom:24px;letter-spacing:-0.16px;word-spacing:-0.22px;}
#t6_177{left:517px;bottom:30px;}
#t7_177{left:524px;bottom:24px;letter-spacing:-0.28px;word-spacing:-0.09px;}
#t8_177{left:288px;bottom:860px;letter-spacing:0.11px;word-spacing:-0.55px;}
#t9_177{left:288px;bottom:829px;letter-spacing:0.27px;word-spacing:-0.69px;}
#ta_177{left:1115px;bottom:27px;letter-spacing:0.23px;}
#tb_177{left:35px;bottom:777px;letter-spacing:0.09px;word-spacing:-0.21px;}
#tc_177{left:35px;bottom:754px;letter-spacing:0.13px;word-spacing:0.05px;}
#td_177{left:35px;bottom:731px;letter-spacing:0.05px;word-spacing:0.13px;}
#te_177{left:35px;bottom:707px;letter-spacing:0.18px;word-spacing:0.01px;}
#tf_177{left:35px;bottom:684px;letter-spacing:0.2px;}
#tg_177{left:35px;bottom:661px;letter-spacing:0.03px;word-spacing:0.16px;}
#th_177{left:35px;bottom:638px;letter-spacing:0.14px;word-spacing:-0.82px;}
#ti_177{left:35px;bottom:614px;letter-spacing:0.17px;word-spacing:0.02px;}
#tj_177{left:35px;bottom:591px;letter-spacing:0.17px;word-spacing:0.02px;}
#tk_177{left:274px;bottom:599px;letter-spacing:-0.01px;}
#tl_177{left:297px;bottom:591px;letter-spacing:0.14px;word-spacing:0.05px;}
#tm_177{left:35px;bottom:568px;letter-spacing:0.18px;}
#tn_177{left:35px;bottom:545px;letter-spacing:0.14px;word-spacing:-0.39px;}
#to_177{left:35px;bottom:522px;letter-spacing:0.11px;word-spacing:-0.8px;}
#tp_177{left:35px;bottom:498px;letter-spacing:0.08px;word-spacing:0.1px;}
#tq_177{left:35px;bottom:475px;letter-spacing:0.19px;word-spacing:-0.01px;}
#tr_177{left:94px;bottom:475px;}
#ts_177{left:110px;bottom:475px;letter-spacing:0.23px;word-spacing:-0.05px;}
#tt_177{left:35px;bottom:436px;letter-spacing:0.1px;word-spacing:0.08px;}
#tu_177{left:35px;bottom:413px;letter-spacing:0.13px;word-spacing:-0.69px;}
#tv_177{left:35px;bottom:390px;letter-spacing:0.09px;word-spacing:0.1px;}
#tw_177{left:35px;bottom:366px;letter-spacing:0.13px;word-spacing:-0.62px;}
#tx_177{left:35px;bottom:343px;letter-spacing:0.07px;word-spacing:0.12px;}
#ty_177{left:35px;bottom:320px;letter-spacing:0.06px;word-spacing:-0.43px;}
#tz_177{left:35px;bottom:297px;letter-spacing:0.15px;word-spacing:0.04px;}
#t10_177{left:35px;bottom:273px;letter-spacing:0.14px;word-spacing:0.04px;}
#t11_177{left:35px;bottom:250px;letter-spacing:0.26px;}
#t12_177{left:64px;bottom:258px;letter-spacing:0.1px;}
#t13_177{left:109px;bottom:250px;letter-spacing:0.09px;word-spacing:0.09px;}
#t14_177{left:35px;bottom:227px;letter-spacing:0.11px;word-spacing:0.08px;}
#t15_177{left:35px;bottom:204px;letter-spacing:0.11px;word-spacing:0.07px;}
#t16_177{left:35px;bottom:181px;letter-spacing:0.12px;word-spacing:0.07px;}
#t17_177{left:237px;bottom:188px;letter-spacing:-0.01px;}
#t18_177{left:260px;bottom:181px;letter-spacing:-0.06px;word-spacing:0.25px;}
#t19_177{left:35px;bottom:157px;letter-spacing:0.19px;}
#t1a_177{left:35px;bottom:134px;letter-spacing:0.12px;word-spacing:0.07px;}
#t1b_177{left:35px;bottom:111px;letter-spacing:-0.01px;}
#t1c_177{left:111px;bottom:118px;letter-spacing:0.1px;}
#t1d_177{left:618px;bottom:777px;letter-spacing:0.11px;word-spacing:-0.94px;}
#t1e_177{left:618px;bottom:754px;letter-spacing:0.13px;word-spacing:-1.18px;}
#t1f_177{left:968px;bottom:754px;letter-spacing:0.07px;word-spacing:-1.11px;}
#t1g_177{left:618px;bottom:731px;letter-spacing:0.16px;word-spacing:0.02px;}
#t1h_177{left:618px;bottom:707px;letter-spacing:0.1px;word-spacing:-1.15px;}
#t1i_177{left:618px;bottom:684px;letter-spacing:0.03px;word-spacing:0.29px;}
#t1j_177{left:618px;bottom:661px;letter-spacing:-0.01px;word-spacing:0.2px;}
#t1k_177{left:618px;bottom:638px;letter-spacing:0.07px;word-spacing:0.11px;}
#t1l_177{left:618px;bottom:614px;letter-spacing:0.15px;word-spacing:0.04px;}
#t1m_177{left:618px;bottom:591px;letter-spacing:0.15px;word-spacing:0.05px;}
#t1n_177{left:618px;bottom:568px;letter-spacing:0.08px;word-spacing:-0.51px;}
#t1o_177{left:618px;bottom:545px;letter-spacing:0.13px;word-spacing:-1.17px;}
#t1p_177{left:618px;bottom:522px;letter-spacing:0.18px;word-spacing:0.01px;}
#t1q_177{left:768px;bottom:522px;letter-spacing:0.24px;word-spacing:-0.05px;}
#t1r_177{left:985px;bottom:522px;letter-spacing:0.12px;word-spacing:0.07px;}
#t1s_177{left:618px;bottom:498px;letter-spacing:0.08px;word-spacing:0.1px;}
#t1t_177{left:618px;bottom:475px;letter-spacing:0.06px;word-spacing:0.13px;}
#t1u_177{left:874px;bottom:483px;letter-spacing:-0.01px;}
#t1v_177{left:897px;bottom:475px;letter-spacing:0.04px;word-spacing:0.14px;}
#t1w_177{left:618px;bottom:452px;letter-spacing:0.04px;word-spacing:0.15px;}
#t1x_177{left:618px;bottom:413px;letter-spacing:0.11px;word-spacing:0.08px;}
#t1y_177{left:618px;bottom:390px;letter-spacing:0.12px;word-spacing:0.07px;}
#t1z_177{left:618px;bottom:366px;letter-spacing:0.09px;word-spacing:0.09px;}
#t20_177{left:618px;bottom:343px;letter-spacing:0.15px;word-spacing:0.04px;}
#t21_177{left:618px;bottom:320px;letter-spacing:0.24px;word-spacing:-0.05px;}
#t22_177{left:836px;bottom:320px;letter-spacing:0.13px;word-spacing:0.06px;}
#t23_177{left:618px;bottom:297px;letter-spacing:-0.02px;word-spacing:0.21px;}
#t24_177{left:725px;bottom:297px;letter-spacing:0.2px;word-spacing:-0.01px;}
#t25_177{left:1089px;bottom:297px;letter-spacing:0.31px;}
#t26_177{left:618px;bottom:273px;letter-spacing:0.22px;word-spacing:-0.02px;}
#t27_177{left:763px;bottom:273px;letter-spacing:0.14px;word-spacing:0.04px;}
#t28_177{left:618px;bottom:235px;letter-spacing:-0.11px;word-spacing:0.53px;}
#t29_177{left:618px;bottom:211px;letter-spacing:0.13px;word-spacing:0.05px;}
#t2a_177{left:1038px;bottom:211px;letter-spacing:0.23px;word-spacing:-0.05px;}
#t2b_177{left:618px;bottom:188px;letter-spacing:0.11px;word-spacing:-1.15px;}
#t2c_177{left:968px;bottom:188px;letter-spacing:0.19px;word-spacing:-1.23px;}
#t2d_177{left:618px;bottom:165px;letter-spacing:0.02px;word-spacing:0.17px;}
#t2e_177{left:23px;bottom:915px;letter-spacing:-0.14px;}

.s0_177{font-size:10px;font-family:ArialMT_5tg;color:#000;}
.s1_177{font-size:6px;font-family:ArialMT_5tg;color:#000;}
.s2_177{font-size:28px;font-family:Arial-BoldMT_5te;color:#000;}
.s3_177{font-size:17px;font-family:Arial-BoldMT_5te;color:#000;}
.s4_177{font-size:17px;font-family:ArialMT_5tg;color:#000;}
.s5_177{font-size:11px;font-family:ArialMT_5tg;color:#000;}
.s6_177{font-size:17px;font-family:Arial-ItalicMT_kb;color:#000;}
.s7_177{font-size:16px;font-family:Arial-BoldItalicMT_kg;color:#000;}
.s8_177{font-size:11px;font-family:Helvetica, Arial, sans-serif;color:#000;}
</style>
<style id="fonts177" type="text/css" >

@font-face {
	font-family: Arial-BoldItalicMT_kg;
	src: url("fonts/Arial-BoldItalicMT_kg.woff") format("woff");
}

@font-face {
	font-family: Arial-BoldMT_5te;
	src: url("fonts/Arial-BoldMT_5te.woff") format("woff");
}

@font-face {
	font-family: Arial-ItalicMT_kb;
	src: url("fonts/Arial-ItalicMT_kb.woff") format("woff");
}

@font-face {
	font-family: ArialMT_5tg;
	src: url("fonts/ArialMT_5tg.woff") format("woff");
}

</style>
<div id="pg177Overlay" style="width:100%; height:100%; position:absolute; z-index:1; background-color:rgba(0,0,0,0); -webkit-user-select: none;"></div>
<div id="pg177" style="-webkit-user-select: none;"><object width="1210" height="935" data="177/177.svg" type="image/svg+xml" id="pdf177" style="width:1210px; height:935px; z-index: 0;"></object></div>
<div class="text-container"><span id="t1_177" class="t s0_177">Version 4.2024 © 2024 National Comprehensive Cancer Network </span>
<span id="t2_177" class="t s1_177">© </span>
<span id="t3_177" class="t s0_177">(NCCN </span>
<span id="t4_177" class="t s1_177">© </span>
<span id="t5_177" class="t s0_177">), All rights reserved. NCCN Guidelines </span>
<span id="t6_177" class="t s1_177">® </span>
<span id="t7_177" class="t s0_177">and this illustration may not be reproduced in any form without the express written permission of NCCN. </span>
<span id="t8_177" class="t s2_177">NCCN Guidelines Version 4.2024 </span>
<span id="t9_177" class="t s2_177">Head and Neck Cancers </span>
<span id="ta_177" class="t s3_177">MS-36 </span>
<span id="tb_177" class="t s4_177">laryngopharyngectomy and postoperative RT, or to systemic therapy with </span>
<span id="tc_177" class="t s4_177">cisplatin and 5-FU for a maximum of three cycles, followed by definitive </span>
<span id="td_177" class="t s4_177">RT. In contrast to a similar approach used for laryngeal cancer, a </span>
<span id="te_177" class="t s4_177">complete response to induction chemotherapy was required before </span>
<span id="tf_177" class="t s4_177">proceeding with definitive RT. The published results showed equivalent </span>
<span id="tg_177" class="t s4_177">survival, with median survival duration and a 3-year survival rate of 25 </span>
<span id="th_177" class="t s4_177">months and 43% (95% CI, 27%–59%), respectively, for the surgery group </span>
<span id="ti_177" class="t s4_177">versus 44 months and 57% (95% CI, 42%–72%), respectively, for the </span>
<span id="tj_177" class="t s4_177">induction chemotherapy group. </span>
<span id="tk_177" class="t s5_177">290 </span>
<span id="tl_177" class="t s4_177">A functioning larynx was preserved in </span>
<span id="tm_177" class="t s4_177">42% of patients who did not undergo surgery. Local or regional failure </span>
<span id="tn_177" class="t s4_177">rates did not differ between the patients treated with surgery and patients </span>
<span id="to_177" class="t s4_177">treated with chemotherapy, although the patients receiving chemotherapy </span>
<span id="tp_177" class="t s4_177">showed a significant reduction in distant metastases as a site of first </span>
<span id="tq_177" class="t s4_177">failure (</span><span id="tr_177" class="t s6_177">P </span><span id="ts_177" class="t s4_177">= .041). </span>
<span id="tt_177" class="t s4_177">For induction chemotherapy as part of a larynx preservation strategy, </span>
<span id="tu_177" class="t s4_177">inclusion of only patients with the specified TNM stages is recommended. </span>
<span id="tv_177" class="t s4_177">Success on larynx preservation with an induction chemotherapy strategy </span>
<span id="tw_177" class="t s4_177">is best established for patients who had a complete response to induction </span>
<span id="tx_177" class="t s4_177">therapy at the primary site and stable or improved disease in the neck. A </span>
<span id="ty_177" class="t s4_177">randomized trial showed that an alternating regimen of cisplatin/5-FU with </span>
<span id="tz_177" class="t s4_177">RT yielded larynx preservation, progression-free interval, and OS rates </span>
<span id="t10_177" class="t s4_177">equivalent to those obtained with induction platinum/5-FU followed by </span>
<span id="t11_177" class="t s4_177">RT. </span>
<span id="t12_177" class="t s5_177">464,465 </span>
<span id="t13_177" class="t s4_177">However, a long-term update from this trial showed that larynx </span>
<span id="t14_177" class="t s4_177">preservation rate was higher in patients who were randomized to receive </span>
<span id="t15_177" class="t s4_177">the alternating regimen (32%), compared to patients who received the </span>
<span id="t16_177" class="t s4_177">sequential regimen (25%). </span>
<span id="t17_177" class="t s5_177">465 </span>
<span id="t18_177" class="t s4_177">Given available randomized data </span>
<span id="t19_177" class="t s4_177">demonstrating the superiority of TPF compared with PF for induction </span>
<span id="t1a_177" class="t s4_177">chemoradiation, the triplet is now recommended as induction for this </span>
<span id="t1b_177" class="t s4_177">approach. </span>
<span id="t1c_177" class="t s5_177">302,303 </span>
<span id="t1d_177" class="t s4_177">As noted in the algorithm, surgery is recommended if a partial response or </span>
<span id="t1e_177" class="t s4_177">less occurs after induction chemotherapy (see </span><span id="t1f_177" class="t s6_177">Cancer of the Hypopharynx </span>
<span id="t1g_177" class="t s4_177">in the NCCN Guidelines for Head and Neck Cancers). The nature of the </span>
<span id="t1h_177" class="t s4_177">operation will depend on the stage and extent of the tumor at presentation. </span>
<span id="t1i_177" class="t s4_177">Partial laryngeal surgery may still be considered, although most patients </span>
<span id="t1j_177" class="t s4_177">will require total laryngectomy, and at least a partial pharyngectomy. In </span>
<span id="t1k_177" class="t s4_177">this situation, or when primary surgery is the selected management path, </span>
<span id="t1l_177" class="t s4_177">postoperative systemic therapy/RT is recommended (category 1) for the </span>
<span id="t1m_177" class="t s4_177">adverse pathologic features of extranodal extension and/or positive or </span>
<span id="t1n_177" class="t s4_177">close mucosal margin. For other risk features, clinical judgment should be </span>
<span id="t1o_177" class="t s4_177">used when deciding to use RT alone or when considering adding systemic </span>
<span id="t1p_177" class="t s4_177">therapy to RT (see </span><span id="t1q_177" class="t s6_177">Cancer of the Hypopharynx </span><span id="t1r_177" class="t s4_177">in the NCCN Guidelines </span>
<span id="t1s_177" class="t s4_177">for Head and Neck Cancers). Severe late toxicity appears to be </span>
<span id="t1t_177" class="t s4_177">associated with the amount of RT </span>
<span id="t1u_177" class="t s5_177">297 </span>
<span id="t1v_177" class="t s4_177">and treatment with radiosensitizing </span>
<span id="t1w_177" class="t s4_177">systemic therapy. </span>
<span id="t1x_177" class="t s4_177">Options for patients with T4a, any N disease include: 1) total </span>
<span id="t1y_177" class="t s4_177">laryngopharyngectomy plus neck dissection(s) followed by adjuvant </span>
<span id="t1z_177" class="t s4_177">systemic therapy/RT or RT; 2) enrollment in clinical trials; 3) induction </span>
<span id="t20_177" class="t s4_177">chemotherapy (category 3); or 4) systemic therapy/RT (category 3) (see </span>
<span id="t21_177" class="t s6_177">Cancer of the Hypopharynx </span><span id="t22_177" class="t s4_177">in the NCCN Guidelines for Head and Neck </span>
<span id="t23_177" class="t s4_177">Cancers, and </span><span id="t24_177" class="t s6_177">Primary Systemic Therapy with Concurrent RT </span><span id="t25_177" class="t s4_177">under </span>
<span id="t26_177" class="t s6_177">Systemic Therapy </span><span id="t27_177" class="t s4_177">in the Discussion). </span>
<span id="t28_177" class="t s7_177">Radiation Therapy Fractionation </span>
<span id="t29_177" class="t s4_177">Fractionation for RT is discussed in the algorithm (see </span><span id="t2a_177" class="t s6_177">Cancer of the </span>
<span id="t2b_177" class="t s6_177">Hypopharynx: Principles of Radiation Therapy </span><span id="t2c_177" class="t s4_177">in the NCCN Guidelines for </span>
<span id="t2d_177" class="t s4_177">Head and Neck Cancers). </span>
<span id="t2e_177" class="t s8_177">Printed by Fredd Merc on 8/29/2024 4:45:54 AM. For personal use only. Not approved for distribution. Copyright © 2024 National Comprehensive Cancer Network, Inc., All Rights Reserved. </span></div>

</div>
</body>
</html>
